Does UPADACITINIB Cause Therapy interrupted? 1,741 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,741 reports of Therapy interrupted have been filed in association with UPADACITINIB (Rinvoq). This represents 2.7% of all adverse event reports for UPADACITINIB.
1,741
Reports of Therapy interrupted with UPADACITINIB
2.7%
of all UPADACITINIB reports
2
Deaths
67
Hospitalizations
How Dangerous Is Therapy interrupted From UPADACITINIB?
Of the 1,741 reports, 2 (0.1%) resulted in death, 67 (3.8%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 1,741 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Pneumonia (1,645)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
SECUKINUMAB (1,071)
Which UPADACITINIB Alternatives Have Lower Therapy interrupted Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL